Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-β in cultured human cancer cells

Journal of Nutrition

Volumn 135, Issue 11, 2005, Pages 2687-2693

  Totta, Pierangela ^a   Acconcia, Filippo ^a   Virgili, Fabio ^b   Cassidy, Aedin ^c   Weinberg, Peter D ^d   Rimbach, Gerald ^e   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

17 estradiol; Apoptotic cascade; Daidzein metabolites; Estrogen receptor; Gene transcription

Indexed keywords

ANTIESTROGEN; CASPASE 3; DAIDZEIN; DRUG METABOLITE; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; METABOLITE; PHOSPHORYLATION; PROMOTER REGION;

EID: 31544448040     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/135.11.2687     Document Type: Article

References (40)

1. Hollman PC, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol. 1999;37:937-42.
2. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther. 2001 May-Jun;90(2-3):157-77.
3. Middleton E Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000 Dec;52(4):673-751.
4. Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF, Mabry TJ. Flavonoid effects relevant to cancer. J Nutr. 2002;132(11 Suppl):3482S-9.
5. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002 Dec 30;113 Suppl 9B:71S-88.
6. Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr. 2004;79:282-8.
7. Magee PJ, McGlynn H, Rowland IR. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett. 2004 May 10;208(1):35-41.
8. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol. 1999; 32:279-86.
9. Harper A, Kerr DJ, Gescher A, Chipman JK. Antioxidant effects of isoflavonoids and lignans, and protection against DNA oxidation. Free Radic Res. 1999 Aug;31(2):149-60.
10. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-Å. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology. 1997;138:863-70.
11. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson J-Å. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 1998;139:4252-63.
12. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 2004;64:423-8.
13. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson J-Å. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1566-71.
14. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M. Survival versus apoptotic 17β-estradiol effect: role of ER α and ER β activated non-genomic signaling. J Cell Physiol. 2005 Apr;203(1):193-201.
15. Totta P, Acconcia F, Leone S, Cardillo I, Marino M. Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor α and β signalling. IUBMB Life. 2004;56:491-9.
16. Virgili F, Acconcia F, Ambra R, Rinna A, Totta P, Marino M. Nutritional flavonoids modulate estrogen receptor α signaling. IUBMB Life. 2004;56:145-51.
17. Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soy consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomark Prev. 1996;5:63-70.
18. Bayer T, Colnot T, Dekant W. Disposition and biotransformation of the estrogenic isoflavone daidzein in rats. Toxicol Sci. 2001 Aug;62(2):205-11.
19. Selvaraj V, Zakroczymski MA, Naaz A, Mukai M, Ju YH, Doerge DR, Katzenellenbogen JA, Helferich WG, Cooke PS. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. Biol Reprod. 2004 Sep;71(3):966-72.
20. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84.
21. Rimbach G, De Pascual T-S, Ewins BA, Matsugo S, Uchida Y, Minihane AM, Turner R, Vafei AK, Weinberg PD. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica. 2003;33:913-25.
22. Turner R, Baron T, Wolffram S, Minihane AM, Cassidy A, Rimbach G, Weinberg PD. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic Res. 2004;38:209-16.
23. Marino M, Acconcia F, Trentalance A. Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell. 2003;14:2583-91.
24. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M. Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res. 1998 Aug 1;26(15):3505-12.
25. Marino M, Distefano E, Caporali S, Ceracchi G, Pallottini V, Trentalance A. β-estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells. J Cell Physiol. 2001 Aug;188(2):170-7.
26. + exchanger in rat aortic smooth muscle cells: physiopathological implications. Endocrinology. 2003;144:4315-24.
27. Karakaya S. Bioavailability of phenolic compounds. Crit Rev Food Sci Nutr. 2004;44:453-64.
28. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14138-43.
29. Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, van der Burg B. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci. 1999 Mar;48(1):55-66.
30. Meerts IATM, Letcher RJ, Hoving S, Marsh G, Bergman A, Lemmen JG, van der Burg B, Brouwer A. In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. Environ Health Perspect. 2001;109:399-407.
31. Rivas A, Lacroix M, Olea-Serrano F, Laios I, Leclercq G, Olea N. Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2002 Sep;82(1):45-53.
32. Freyberger A, Schmuck G. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay. Toxicol Lett. 2005;155:1-13.
33. Singh SU, Casper RF, Fritz PC, Sukhu B, Ganss B, Girard B Jr, Savouret JF, Tenenbaum HC. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol. 2000 Oct;167(1):183-95.
34. Lee JE, Safe S. 3′,4′-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol Sci. 2000 Dec;58(2):235-42.
35. Jordan VC. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. J Med Chem. 2003 Mar 13;46(6):883-908.
36. Le Bail JC, Varnat F, Nicolas JC, Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 1998 Aug 14;130(1-2):209-16.
37. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, Andò S. Estrogen receptor α mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001 Sep;60(3):595-602.
38. Guo JM, Kang GZ, Xiao BX, Liu DH, Zhang S. Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):882-8.
39. Rafii F, Davis C, Park M, Heinze TM, Beger RD. Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals. Arch Microbiol. 2003 Jul;180(1):11-6.
40. Hur HG, Beger RD, Heinze TM, Lay JO Jr., Freeman JP, Dore J, Rafii F. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Arch Microbiol. 2002 Jul;178(1):8-12.